Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement

Psychopharmacology

Volumn 201, Issue 4, 2009, Pages 557-568

  Coen, Kathleen M ^a   Adamson, K Laurel ^a   Corrigall, William A ^b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Bupropion; Dihydro erythroidine; Dopamine reuptake; Fixed ratio; Nicotine; Norepinephrine reuptake; Progressive ratio; Self administration

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; NICOTINE; NISOXETINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; MALE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SMOKING CESSATION; TOBACCO DEPENDENCE;

ANIMALS; BUPROPION; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; INFUSIONS, INTRAVENOUS; MALE; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; RATS; RATS, LONG-EVANS; RECEPTORS, NICOTINIC; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SMOKING CESSATION;

EID: 57049176619     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1321-6     Document Type: Article

References (68)

1. JM Arnold DC Roberts 1997 A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement Pharmacol Biochem Behav 57 441 447
2. AC Barrett JR Miller JM Dohrmann SB Caine 2004 Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats Neuropharmacology 47 Suppl 1 256 273
3. ME Benwell DJ Balfour 1997 Regional variation in the effects of nicotine on catecholamine overflow in rat brain Eur J Pharmacol 325 13 20
4. AW Bruijnzeel A Markou 2003 Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats Synapse 50 20 28
5. AR Caggiula EC Donny AR White N Chaudhri S Booth MA Gharib A Hoffman KA Perkins AF Sved 2001 Cue dependency of nicotine self-administration and smoking Pharmacol Biochem Behav 70 515 530
6. N Chaudhri AR Caggiula EC Donny S Booth M Gharib L Craven MI Palmatier X Liu AF Sved 2007 Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule Psychopharmacology (Berl) 190 353 362
7. WA Corrigall KM Coen 1989 Nicotine maintains robust self-administration in rats on a limited-access schedule Psychopharmacology (Berl) 99 473 478
8. WA Corrigall KM Coen KL Adamson 1994 Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area Brain Res 653 278 284
9. WA Corrigall KM Coen J Zhang KL Adamson 2001 GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat Psychopharmacology (Berl) 158 190 197
10. MS Cousins HM Stamat H de Wit 2001 Acute doses of d-amphetamine and bupropion increase cigarette smoking Psychopharmacology (Berl) 157 243 253
11. EC Donny AR Caggiula S Knopf C Brown 1995 Nicotine self-administration in rats Psychopharmacology 122 190 194
12. EC Donny AR Caggiula MM Mielke S Booth MA Gharib A Hoffman V Maldovan C Shupenko SE McCallum 1999 Nicotine self-administration in rats on a progressive ratio schedule of reinforcement Psychopharmacology (Berl) 147 135 142
13. LP Dwoskin AS Rauhut KA King-Pospisil MT Bardo 2006 Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent CNS Drug Rev 12 178 207
14. R Felix ED Levin 1997 Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats Neuroscience 81 1009 1017
15. Y Fu SG Matta TJ James BM Sharp 1998 Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors J Pharmacol Exp Ther 284 1188 1196
16. Y Fu SG Matta VG Brower BM Sharp 2001 Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study J Neurosci 21 8979 8989
17. Y Fu SG Matta VB Kane BM Sharp 2003 Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study Neuropharmacology 45 514 523
18. SD Glick IM Maisonneuve BA Kitchen 2002 Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors Eur J Pharmacol 448 185 191
19. AJ Grottick G Trube WA Corrigall J Huwyler P Malherbe R Wyler GA Higgins 2000 Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine J Pharmacol Exp Ther 294 1112 1119
20. K Guillem C Vouillac MR Azar LH Parsons GF Koob M Cador L Stinus 2006 Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats Eur J Neurosci 24 3532 3540
21. AC Harris PR Pentel MG Lesage 2007 Prevalence, magnitude, and correlates of an extinction burst in drug-seeking behavior in rats trained to self-administer nicotine during unlimited access (23 h/day) sessions Psychopharmacology 194 395 402
22. AA Harrison F Gasparini A Markou 2002 Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats Psychopharmacology (Berl) 160 56 66
23. EC Hennings JP Kiss K De Oliveira PT Toth ES Vizi 1999 Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices J Neurochem 73 1043 1050
24. LL Howell LD Byrd 1991 Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey J Pharmacol Exp Ther 258 178 185
25. LL Howell KM Wilcox 2001 The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates J Pharmacol Exp Ther 298 1 6
26. PJ Kenny A Markou 2006 Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity Neuropsychopharmacology 31 1203 1211
27. HL Kimmel SG Holtzman 1998 Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat Eur J Pharmacol 343 119 127
28. AJ Lanca KL Adamson KM Coen BL Chow WA Corrigall 2000 The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study Neuroscience 96 735 742
29. C Lerman MG Lesage KA Perkins SS O'Malley SJ Siegel NL Benowitz WA Corrigall 2007 Translational research in medication development for nicotine dependence Nat Rev Drug Discov 6 746 762
30. MG LeSage DE Keyler D Shoeman D Raphael G Collins PR Pentel 2002 Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine Pharmacol Biochem Behav 72 279 289
31. MG LeSage DE Keyler G Collins PR Pentel 2003 Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations Psychopharmacology (Berl) 170 278 286
32. KP Lindsey KM Wilcox JR Votaw MM Goodman C Plisson FI Carroll KC Rice LL Howell 2004 Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging J Pharmacol Exp Ther 309 959 969
33. DH Malin JR Lake TP Upchurch M Shenoi N Rajan WE Schweinle 1998 Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine Pharmacol Biochem Behav 60 609 613
34. RS Mansbach LK Chambers CC Rovetti 2000 Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine Psychopharmacology (Berl) 148 234 242
35. A Markou F Weiss LH Gold SB Caine G Schulteis GF Koob 1993 Animal models of drug craving Psychopharmacology (Berl) 112 163 182
36. A McGregor DC Roberts 1993 Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement Brain Res 624 245 252
37. A McGregor DC Roberts 1995 Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement Behav Brain Res 67 75 80
38. DK Miller EH Wong MD Chesnut LP Dwoskin 2002 Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors J Pharmacol Exp Ther 302 687 695
39. NE Paterson A Markou 2004 Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats Psychopharmacology 173 64 72
40. NE Paterson A Markou 2005 The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats Psychopharmacology 179 255 261
41. NE Paterson W Froestl A Markou 2004 The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat Psychopharmacology (Berl) 172 179 186
42. NE Paterson S Semenova A Markou 2008 The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat Psychopharmacology 198 351 362
43. KA Perkins JE Grobe RL Stiller C Fonte JE Goettler 1992 Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior Clin Pharmacol Ther 52 627 634
44. KA Perkins C Lerman J Keenan C Fonte S Coddington 2004 Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers Nicotine Tob Res 6 501 507
45. S Rahman J Zhang WA Corrigall 2004 Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure Neurochem Res 29 1687 1693
46. AS Rauhut SN Mullins LP Dwoskin MT Bardo 2002 Reboxetine: attenuation of intravenous nicotine self-administration in rats J Pharmacol Exp Ther 303 664 672
47. AS Rauhut N Neugebauer LP Dwoskin MT Bardo 2003 Effect of bupropion on nicotine self-administration in rats Psychopharmacology (Berl) 169 1 9
48. DC Roberts SA Bennett GJ Vickers 1989 The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats Psychopharmacology (Berl) 98 408 411
49. H Rollema LK Chambers JW Coe J Glowa RS Hurst LA Lebel Y Lu RS Mansbach RJ Mather CC Rovetti SB Sands E Schaeffer DW Schulz FD Tingley 3rd KE Williams 2007 Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 985 994
50. RB Rothman JR Glowa 1995 A review of the effects of dopaminergic agents on humans, animals, and drug seeking behavior, and its implications for medication development. Focus on GBR 12909 Mol Neurobiol 11 1 19
51. S Schenk 2002 Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats Psychopharmacology (Berl) 160 263 270
52. BM Sharp SG Matta 1993 Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization Endocrinology 133 11 19
53. M Shoaib N Sidhpura S Shafait 2003 Investigating the actions of bupropion on dependence-related effects of nicotine in rats Psychopharmacology (Berl) 165 405 412
54. P Skjoldager G Winger JH Woods 1993 Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys Drug Alcohol Depend 33 31 39
55. D Stafford MG LeSage KC Rice JR Glowa 2001 A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule Drug Alcohol Depend 62 41 47
56. AK Stoker S Semenova A Markou 2008 Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice Neuropsychopharmacol 54 1223 1232
57. IP Stolerman CJ Chandler HS Garcha JM Newton 1997 Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats Psychopharmacology (Berl) 129 390 397
58. KL Summers E Giacobini 1995 Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex Neurochem Res 20 753 759
59. BK Szasz ES Vizi JP Kiss 2007 Nicotinic acetylcholine receptor antagonistic property of the selective dopamine uptake inhibitor, GBR-12909 in rat hippocampal slices Neuroscience 145 344 349
60. SR Tella 1995 Effects of monoamine reuptake inhibitors on cocaine self-administration in rats Pharmacol Biochem Behav 51 687 692
61. TD Tyler RE Tessel 1979 Amphetamine's locomotor stimulant and norepinephrine-releasing effects: evidence for selective antagonist by nisoxetine Psychopharmacology 64 291 296
62. CL Walters S Brown JP Changeux B Martin MI Damaj 2006 The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice Psychopharmacology (Berl) 184 339 344
63. SS Watkins MP Epping-Jordan GF Koob A Markou 1999 Blockade of nicotine self-administration with nicotinic antagonists in rats Pharmacol Biochem Behav 62 743 751
64. SS Watkins L Stinus GF Koob A Markou 2000 Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects J Pharmacol Exp Ther 292 1053 1064
65. JR Weeks 1981 An improved pneumatic syringe for self-administration of drugs by rats Pharmacol Biochem Behav 14 573 574
66. D Weinshenker JP Schroeder 2007 There and back again: a tale of norepinephrine and drug addiction Neuropsychopharmacology 32 1433 1451
67. M Williams JL Robinson 1984 Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue J Neurosci 4 2906 2911
68. J Zhou 2004 Norepinephrine transporter inhibitors and their therapeutic potential Drugs Future 29 1235 1244